Drug Profile
Research programme: factor Xa inhibitors - Mochida
Alternative Names: M 55165; M 55529; M 55532; M 55551; M 65644Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator Mochida Pharmaceutical
- Class Piperazines; Piperidines; Spiro compounds
- Mechanism of Action Factor Xa inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Thrombosis
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Thrombosis in Japan
- 10 Apr 2006 A preclinical study has been added to the pharmacokinetics and Thromboses pharmacodynamics sections
- 20 Sep 2005 Data presented at the 230th American Chemical Society National Meeting (230th-ACS-2005) have been added to the adverse events, pharmacokinetics and Thromboses pharmacodynamics sections